Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("HERTENSTEIN, B")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 37

  • Page / 2
Export

Selection :

  • and

Allogenic bone marrow transplantation of chemotherapy for patients with acute myeloid leukemia in first complete remission : a decision analysis approachHERTENSTEIN, B; HEIL, G; HEIMPEL, H et al.Annals of hematology (Print). 1996, Vol 72, Num 4, pp 223-230, issn 0939-5555Article

Counting the cost: markers of endothelial damage in hematopoietic stem cell transplantationWOYWODT, A; HAUBITZ, M; BUCHHOLZ, S et al.Bone marrow transplantation (Basingstoke). 2004, Vol 34, Num 12, pp 1015-1023, issn 0268-3369, 9 p.Article

Orbitale und okuläre Mucormykose = Mucormycose orbitaire et oculaire = Orbital and ocular mucormycosisPITTKE, E. C; HERTENSTEIN, B; BACHOR, R et al.Klinische Monatsblätter für Augenheilkunde. 1987, Vol 190, Num 6, pp 530-533, issn 0023-2165Article

Nonmyeloablative stem cell transplantation in adults with high-risk ALL may be effective in early but not in advanced diseaseARNOLD, R; MASSENKEIL, G; KOLB, H. J et al.Leukemia. 2002, Vol 16, Num 12, pp 2423-2428, issn 0887-6924, 6 p.Article

Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantationCHAMPLIN, R. E; SCHMITZ, N; KLEIN, J. P et al.Blood. 2000, Vol 95, Num 12, pp 3702-3709, issn 0006-4971Article

Successful therapy with donor buffy coat transfusions in patients with relapsed chronic myeloid leukemia after bone marrow transplantation is associated with high frequencies of host-reactive interleukin 2-secreting T helper cellsBUNJES, D; THEOBALD, M; HERTENSTEIN, B et al.Bone marrow transplantation (Basingstoke). 1995, Vol 15, Num 5, pp 713-719, issn 0268-3369Article

Phasen der Rehabilitation knochenmarktransplantierter Patienten und Patientinnen = Phases of rehabilitation of bone marrow transplanted patientsARNOLD, R; BERGERHOFF, P; DENZINGER, R et al.PPmP. Psychotherapie, Psychosomatik, medizinische Psychologie. 1992, Vol 42, Num 6, pp 191-200, issn 0937-2032Article

T-cell depletion versus methotrexate as GvHD-prophylaxis in allogeneic bone marrow transplantation for leukaemiaWIESNETH, M; HERTENSTEIN, B; BUNJES, D et al.European journal of haematology. 1988, Vol 41, Num 3, pp 243-249, issn 0902-4441Article

Fractionated total body irradiation and high-dose VP 16-213 followed by allogeneic bone marrow transplantation in advanced leukemiasSCHMITZ, N; GASSMANN, W; LÖFFLER, H et al.Blood. 1988, Vol 72, Num 5, pp 1567-1573, issn 0006-4971Article

Aggressive polychemotherapy for acute myelofibrosisHERTENSTEIN, B; KURRLE, E; FRICKHOFEN, N et al.European journal of haematology. 1990, Vol 44, Num 4, pp 213-219, issn 0902-4441Article

Dose-escalated treosulphan in combination with cyclophosphamide as a new preparative regimen for allogeneic haematopoietic stem cell transplantation in patients with an increased risk for regimen-related complicationsBEELEN, D. W; TRENSCHEL, R; BAUMGART, J et al.Bone marrow transplantation (Basingstoke). 2005, Vol 35, Num 3, pp 233-241, issn 0268-3369, 9 p.Article

A new conditioning regimen involving total marrow irradiation, busulfan and cyclophosphamide followed by autologous PBSCT in patients with advanced multiple myelomaEINSELE, H; BAMBERG, M; KRÖGER, N et al.Bone marrow transplantation (Basingstoke). 2003, Vol 32, Num 6, pp 593-599, issn 0268-3369, 7 p.Article

Effect of topical oral G-CSF on oral mucositis: a randomised placebo-controlled trialKARTHAUS, M; ROSENTHAL, C; GANSER, A et al.Bone marrow transplantation (Basingstoke). 1998, Vol 22, Num 8, pp 781-785, issn 0268-3369Article

Immune thyroiditis after transplantation of allogeneic CD34+selected peripheral blood cellsKARTHAUS, M; GABRYSIAK, T; BRABANT, G et al.Bone marrow transplantation (Basingstoke). 1997, Vol 20, Num 8, pp 697-699, issn 0268-3369Article

In vivo/ex vivo T cell depletion for GVHD prophylaxis influences onset and course of active cytomegalovirus infection and disease after BMTHERTENSTEIN, B; HAMPL, W; BUNJES, D et al.Bone marrow transplantation (Basingstoke). 1995, Vol 15, Num 3, pp 387-393, issn 0268-3369Article

In vivo/ex vivo T cell depletion reduces the morbidity of allogeneic bone marrow transplantation in patients with acute leukaemias in first remission without increasing the risk of treatment failure : comparison with cyclosporin/methotrexateBUNJES, D; HERTENSTEIN, B; WIESNETH, M et al.Bone marrow transplantation (Basingstoke). 1995, Vol 15, Num 4, pp 563-568, issn 0268-3369Article

Cardiac toxicity of bone marrow transplantation : predictive value of cardiologic evaluation before transplantHERTENSTEIN, B; STEFANIC, M; ADAM, W.-E et al.Journal of clinical oncology. 1994, Vol 12, Num 5, pp 998-1004, issn 0732-183XArticle

HLA-DR4 is associated with a diminished risk of the development of chronic myeloid leukemia (CML)POSTHUMA, E. F. M; FALKENBURG, J. H. F; ROOSNEK, E et al.Leukemia. 2000, Vol 14, Num 5, pp 859-862, issn 0887-6924Conference Paper

Complete haematological and cytogenetic response to interferon alpha-2a of a myeloproliferative disorder with eosinophilia associated with a unique t(4;7) aberrationSCHÖFFSKI, P; GANSER, A; PASCHEBERG, U et al.Annals of hematology (Print). 2000, Vol 79, Num 2, pp 95-98, issn 0939-5555Article

Chronic myeloid leukemia in accelerated phase : Treatment results with conventional chemotherapy and allogeneic bone marrow transplantation in 96 patientsGRIESSHAMMER, M; ARNOLD, R; BANGERTER, M et al.European journal of haematology. 1998, Vol 61, Num 1, pp 7-13, issn 0902-4441Article

Sustained decrease of peripheral lymphocytes after allogeneic blood stem cell apheresesNOVOTNY, J; KADAR, J; HERTENSTEIN, B et al.British journal of haematology. 1998, Vol 100, Num 4, pp 695-697, issn 0007-1048Article

Antibodies to interferon-α : a novel type of autoantibody occurring after allogeneic bone marrow transplantationPRÜMMER, O; BUNJES, D; WIESNETH, M et al.Bone marrow transplantation (Basingstoke). 1996, Vol 17, Num 4, pp 617-623, issn 0268-3369Article

Emergence of CD52-, phosphatidylinositolglycan-anchor-deficient T lymphocytes after in vivo application of Campath-1H for refractory B-cell non-Hodgkin lymphomaHERTENSTEIN, B; WAGNER, B; BUNJES, D et al.Blood. 1995, Vol 86, Num 4, pp 1487-1492, issn 0006-4971Article

Building a cytology report database: a computer-assisted system for documentation, evaluation and hospital-wide recall of haematological biopsy reportsHOHNLOSER, J. H; KÖNIG, A; FISCHER, M. R. G et al.Medical informatics (1985). 1994, Vol 19, Num 3, pp 199-208, issn 0959-8316Article

Treatment of steroid-resistant acute graft-vs-host disease after allogeneic marrow transplantation with anti-interleukin-2 receptor antibody (BT563)HERTENSTEIN, B; STEFANIC, M; SANDHERR, M et al.Transplantation proceedings. 1994, Vol 26, Num 6, pp 3114-3116, issn 0041-1345Conference Paper

  • Page / 2